PhoenixBio Co.,Ltd. (6190)

Market cap
¥1.7B
P/E ratio
15.9x
Phoenix Bio provides pharmaceutical testing services using PXB mice with human liver cells to help drug companies predict how medicines work in people.
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 20251,717-19.45%
Mar 31, 20242,132-6.98%
Mar 31, 20232,292+23.61%
Mar 31, 20221,854+3.05%
Mar 31, 20211,799-20.28%
Mar 31, 20202,257+98.88%
Mar 31, 20191,135-15.48%
Mar 31, 20181,343-30.30%
Mar 31, 20171,927+2.05%
Mar 31, 20161,888+103.98%
Mar 31, 2015926
AI Chat